Biogerontology Laboratory People
Prof David LeCouteur
A/Prof Victoria Cogger
Dr Alessandra Warren
Dr Samantha Solon
Porfessor Robin Fraser
Dr Rahul Gokarn
The Biogerontology Group
Professor David Le Couteur AO
Professor of Medicine
Scientific Director, Ageing and Alzheimers Institute
Director, Centre for Education and Research on Ageing
Director, Biogerontology Laboratory, ANZAC Research Institute
Concord Repatriation General Hospital
David Le Couteur is Professor of Geriatric Medicine at the University of Sydney, Scientific Director of the Ageing and Alzheimers Institute (Concord Hospital), Director of the Centre for Education and Research on Ageing (University of Sydney), Director of the Biogerontology Laboratory of the ANZAC Research Institute and Senior Staff Specialist Physician in Geriatric Medicine at the Concord RG Hospital in Sydney.
In 2016 he was awarded an AO for distinguished service to medicine as a clinical pharmacologist and geriatrician, particularly through a range of advisory roles and academic research activities.
He has directed CERA since 2001 which is a large multidisciplinary ageing research organization and a collaborative centre of the International Association for Gerontology and Geriatrics (IAGG) and more recently was appointed Scientific Director of the new Ageing and Alzheimers Institute.
He was president of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT 2011-2013). He is a member of the Council of the International Union for Basic and Clinical Pharmacology (IUPHAR). He was recipient of the American Society for Clinical Pharmacology and Therapeutics 2013 William B Abrams award (for contribution to geriatric clinical pharmacology) and the 2015 Rand Medal of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (for contribution to national and international pharmacology).
He served on several Australian Federal medicines committees: the Pharmaceutical Benefits Advisory Committee (2009-2013) and chaired its Drug Utilization Subcommittee; the Australian Drug Evaluation Committee (1998-2005) and chaired its Pharmaceutical Subcommittee; and the Advisory Committee on the Safety of Medicines (2013-2015). He has served on several education and training committees in the Royal Australasian College of Physicians and is a board member of the Australian Medicines Handbook.
His research is translational gerontology, spanning from biogerontology (nutrition, liver pharmacology and physiology, liver endothelium and ageing); clinical research (geriatric pharmacology and the application of evidence based medicine to older people) and epidemiology (chief investigator and pharmacoepidemiologist on the Concord Health and Ageing Male Project CHAMP).